Collection 期刊論文 [121/121] 會議論文/會議摘要 [5/10] Siblings 劉淦光(2006-2014) [23/23] 劉鴻興 [9/9] 喻秋華 [60/60] 孫以瀚 [1/1] 張仲明 [30/31] 張明姿 [14/14] 張雅媗 [6/6] 徐唯哲 [7/7] 徐欣伶 [19/22] 施修明 [35/39] 松浦功 [21/26] 梁啟銘(2006-2007) [4/4] 江運金 [34/34] 王紹文 [15/15] 王陸海 [35/36] 莊志立 [32/38] 蔡世峯 [134/138] 許惠恒 [36/36] 陳俊宏 [16/16] 陳怡榮 [32/36] 黃麗蓉 [25/25] 龔行健 [61/63] 其他 [154/158] 周玉山(1996-2005) [20/22] 王玲美(2004-2008) [4/4] 葉秀慧(2001-2005) [21/22] 鄭金松(1997-2002) [6/6] 黃奇英(1998-2005) [32/34] Community Statistics 近3年內發表的文件:13(9.92%) 含全文筆數:126(96.18%) 文件下載次數統計 下載大於0次:126(100.00%) 下載大於100次:122(96.83%) 檔案下載總次數:70454(1.31%) 最後更新時間: 2024-11-28 10:33 Top Upload Loading... Top Download Loading... Recent Submissions Chronic active epstein-barr virus i... Comprehensive genomic profiling in ... Study of sex-biased differences in ... The efficacy of multi-disciplinary ... Primary biliary cholangitis with fe... Hepatocellular carcinoma with gastr... Challenges of the eighth edition of... CA10 is associated with HBV-related... Accurate and generalizable quantita... Novel paired cell lines for the stu...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 26-50 of 131. (6 Page(s) Totally) << < 1 2 3 4 5 6 > >> View [10|25|50] records per page

Date	Title	Relation
2019-02-22	Somatic mutations of PREX2 gene in patients with hepatocellular carcinoma	Scientific Reports. 2019 Feb 22;9:Article number 2552.
2019-02	CBAP modulates Akt-dependent TSC2 phosphorylation to promote Rheb-mTORC1 signaling and growth of T-cell acute lymphoblastic leukemia	Oncogene. 2019 Feb;38(9):1432-1447.
2018-12	A novel spontaneous hepatocellular carcinoma mouse model for studying T-cell exhaustion in the tumor microenvironment	Journal for Immunotherapy of Cancer. 2018 Dec;6:Article number 144.
2018-12	Down-regulation of ROR2 promotes prostate cancer metastasis through regulation of miRNAs on PIAS3 expression	Cancer Science. 2018 Dec;109(Suppl. 2):443.
2018-09-14	AAV serotype 8-mediated liver specific GNMT expression delays progression of hepatocellular carcinoma and prevents carbon tetrachloride-induced liver damage	Scientific Reports. 2018 Sep 14;8:Article number 13802.
2018-04	Metabolic risk factors are associated with non‐hepatitis B non‐hepatitis C hepatocellular carcinoma in Taiwan, an endemic area of chronic hepatitis B	Hepatology Communications. 2018 Apr;2(6):747-759.
2017-11-13	Interpretation US elastography in chronic hepatitis B with or without anti-HBV therapy	Applied Sciences. 2017 Nov 13;7(11):Article number 1164.
2017-11	EZH2-mediated upregulation of ROS1 oncogene promotes oral cancer metastasis	Oncogene. 2017 Nov;36(47):6542-6554.
2017-10-24	Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan	Journal of the Formosan Medical Association. 2018 May;117(5):381-403.
2017-09-19	Upregulation of CISD2 augments ROS homeostasis and contributes to tumorigenesis and poor prognosis of lung adenocarcinoma	Scientific Reports. 2017 Sep 19;7:Article number 11893.
2017-06-08	Characterization of a new murine cell line of sarcomatoid hepatocellular carcinoma and its application for biomarker/therapy development	Scientific Reports. 2017 Jun 08;7:Article number 3052.
2017-05	Characterization of the GNMT-HectH9-PREX2 tripartite relationship in the pathogenesis of hepatocellular carcinoma	International Journal of Cancer. 2017 May;140(10):2284-2297.
2017-02	Overexpression of MutL homolog 1 and MutS homolog 2 proteins have reversed prognostic implications for stage I–II colon cancer patients	Biomedical Journal. 2017 Feb;40(1):39-48.
2017-01	A multidisciplinary team care approach improves outcomes in high-risk pediatric neuroblastoma patients	Oncotarget. 2017 Jan;8(3):4360-4372.
2016-12-05	Hepatocarcinogenesis in transgenic mice carrying hepatitis B virus pre-S/S gene with the sW172* mutation	Oncogenesis. 2016 Dec 05;5(12):Article number e273.
2016-07	Carboxypeptidase E is a prediction marker for tumor recurrence in early-stage hepatocellular carcinoma	Tumor Biology. 2016 Jul;37(7):9745-9753.
2016-05-03	Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer	Scientific Reports. 2016 May 3;6:Article number 25369.
2016-05	Selective retention of an inactive allele of the DKK2 tumor suppressor gene in hepatocellular carcinoma	PLoS Genetics. 2016 May;12(5):Article number e1006051.
2016-04	Diagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma	Oncotarget. 2016 Apr;7(14):18774-18786.
2016-04	The hepatitis viral status in patients with hepatocellular carcinoma: A study of 3843 patients from Taiwan liver cancer network	Medicine. 2016 Apr;95(15):Article number e3284.
2015-09	Niemann-Pick type C2 protein regulates liver cancer progression via modulating ERK1/2 pathway: Clinicopathological correlations and therapeutical implications	International Journal of Cancer. 2015 Sep;137(6):1341-1351.
2015-07	Ribose-5-phosphate isomerase A regulates hepatocarcinogenesis via PP2A and ERK signaling	International Journal of Cancer. 2015 Jul 1;137(1):104-115.
2015-07	EGFR over-expression in non-small cell lung cancers harboring EGFR mutations is associated with marked down-regulation of CD82	Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2015 Jul;1852(7):1540-1549.
2015-06	Early radiographic response to epidermal growth factor receptor-tyrosine kinase inhibitor in non-small cell lung cancer patients with epidermal growth factor receptor mutations: A prospective study	Biomedical Journal. 2015 Jun;38(3):221-228.
2015-05	A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer	Annals of Oncology. 2015 May;26(5):943-949.

Showing items 26-50 of 131. (6 Page(s) Totally) << < 1 2 3 4 5 6 > >> View [10|25|50] records per page